Gene Query: CLDND1

Dataset Description Geneva Score
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 68.61
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 60.55
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 57.59
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 53.83
Unique features and clinical importance of acute alloreactive immune responses 50.82
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 46.67
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 46.67
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 46.35
Transcriptomic analysis of human tonsillar TFH subsets 44.0
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 43.64
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 40.32
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 39.81
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 39.81
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 36.29
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 35.38
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 33.62
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 33.57
Transcriptome of Stabilin-1 siRNA transfected human monocytes 32.14
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 31.95
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 31.11
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 30.87
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 29.49
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 29.49
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 29.27
Regulation of highly expressed hCINAP on translatome 28.81
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 28.3
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 27.38
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 27.09
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 26.24
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 24.32
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 24.1
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 24.1
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 23.86
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 23.86
Selective suppression of endothelial cytokine production by progesterone receptor 22.66
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 22.66
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 22.48
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 22.19
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 22.18
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 22.17
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 21.9
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 21.87
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 21.56
Transcription control by the ENL YEATS domain in acute leukemia 21.2
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 21.2
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 21.12
Effect of BB608 on Gene Expression in HNSCC Cell Line 20.75
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 20.65
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 20.45
naive T cell heterogeneity after neonatal thymectomy 20.21
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 19.38
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 19.37
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 19.19
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 18.77
IDH3a KO RNA-seq 18.66
Electronic cigarettes 18.15
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 18.04
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 17.95
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 17.87
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 17.54
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 17.26
Ribosomal footprinting of MDA-Parental and MDA-LM2 17.1
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 17.08
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 17.02
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 16.86
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 16.81
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 16.76
Fbxo32 mediated gene expression program underlies EMT and metastasis 16.33
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 15.85
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 15.74
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 15.68
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 15.19
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 15.09
RNA sequencing of matched nephrectomy samples [RNA-seq] 15.07
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 15.07
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 14.96
mRNA expression profile of Lymphocytes 14.79
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 14.77
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 14.6
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 14.6
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 14.28
RNA sequencing analysis of selumetinib-resistant CRC cells lines 14.26
Effect of from Human Umbilical Vein Endothelial Cells 14.22
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 13.93
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 13.92
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 13.89
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 13.79
The comparison of high-throughput single-cell RNA-seq methods 13.65
Identification of transcription start sites for human A549 cell line using ReCappable-seq 13.58
Ribosomal footprinting of CN34-Parental and CN34-LM1a 13.58
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 13.55
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 13.39
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 13.39
Spliceosomal disruption of the non-canonical BAF complex in cancer 13.32
Genetic-to-epigenetic Therapy for Pancreatic Cancer 13.29
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 13.28
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 13.04
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 13.02
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 12.91
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 12.82
Transcriptomic and gene ontology profiling of the human corneal cell types 12.72
ZIKV infection of monocytes activates inflammasome pathways 12.71
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 12.64
BACH2 in human plasma cell fate decision 12.63
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 12.41
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 12.35
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 12.35
Expression profiling of etoposide-induced senescent cells 12.28
Silencing SPIB in attached and floating state of H1703 lung cancer cells 12.24
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 12.2
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 12.16
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 12.15
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 12.15
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 12.05
SLIGRL-induced gene expression changes in NHEK cells 12.01
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 11.95
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 11.91
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 11.9
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 11.9
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 11.89
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 11.89
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 11.89
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 11.86
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 11.83
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 11.8
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 11.69
Differential analysis of gene regulation at transcript resolution by RNA-Seq 11.51
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 11.51
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 11.43
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 11.39
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 11.39
Alteration of the microRNA network during the progression of Alzheimer’s disease 11.38
Transcriptome analysis of kidney organoids 11.32
Trans-differentiation of human adult peripheral blood T cells into neurons 11.3
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 11.23
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 11.17
Reassessment of Exosome Composition 11.06
Co-transcriptional loading of RNA export factors shapes the human transcriptome 11.06
RNAseq of HEK293 cells after Chtop knockdown 11.06
Transcriptomic profiling of human peripheral blood-derived mast cells 11.06
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 11.06
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 10.98
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 10.93
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 10.92
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 10.84
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 10.84
Gene expression changes associated with resistance to tagraxofusp (SL-401) 10.79
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 10.76
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 10.66
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 10.65
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 10.63
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 10.57
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 10.51
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 10.51
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 10.51
RNA-seq of cells with TET1 knockout 10.5
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 10.47
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 10.29
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 10.24
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 10.14
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 10.14
Be1 and Be2 B cells are transcriptionally distinct 10.13
RNA-seq of human aneuploid cell lines with Trisomy 21 10.12
KLF6-dependent transcription in renal cancer cells 10.04
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 10.02
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 10.01
Gene expression changes after LOC550643 silencing 9.93
Noncoding regions are the main source of targetable tumor-specific antigens 9.88
circRNA-sequencing 9.87
RNA-seq melanoma 9.85
STRIPAK directs PP2A activity to promote oncogenic transformation 9.84
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 9.83
Comparing gene expression in iPSC derived RPE from control and AMD donors 9.82
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 9.8
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 9.79
BAF controls genome accessibility 9.78
PGE2 mediated gene expression changes in human cervical stromal cells 9.74
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 9.71
Altering cancer transcriptomes using epigenomic inhibitors 9.68
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 9.68
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 9.63
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 9.52
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 9.51
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 9.51
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 9.5
KSDM1b Role in Ewing Sarcoma 9.48
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 9.45
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 9.43
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 9.33
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 9.31
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 9.3
Primary human trophoblast from term placenta 9.28
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 9.25
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 9.25
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 9.22
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 9.22
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 9.21
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 9.18
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 9.18
Illumina Total RNA-seq in HeLa 9.15
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 9.15
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 9.07
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 9.07
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 9.04
LncRNA expression profiling of ischemic stroke patients 9.02
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 9.01
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 9.01
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 9.01
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 9.0
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 9.0
Tracking distinct RNA populations using efficient and reversible covalent chemistry 9.0
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 9.0
Global epigenomic reconfiguration during mammalian brain development 8.98
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 8.98
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 8.92
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 8.91
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 8.9
CROP-Seq in Primary Human T Cells 8.8
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 8.73
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 8.73
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 8.72
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 8.72
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 8.72
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 8.7
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 8.68
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 8.67
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 8.65
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 8.65
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 8.64
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 8.63
Transcriptome of diurnal human blood neutrophils 8.62
FOXD3 is a novel tumor suppressor in lung cancer 8.57
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 8.47
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 8.42
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 8.41
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 8.4
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 8.35
RNA-seq analysis of uveal melanoma cells treated with FR900359 8.3
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 8.28
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 8.27
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 8.25
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 8.22
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 8.22
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 8.17
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 8.16
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 8.14
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 8.08
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 8.05
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 8.01
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 7.95
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 7.93
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 7.89
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 7.89
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 7.88
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 7.84
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 7.83
Transcriptome analysis of BAP1 knockout and restoration 7.83
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 7.78
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 7.73
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 7.73
mRNA expression profile of Lymphocytes by high-throuput sequencing 7.73
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 7.68
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 7.68
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 7.67
Differetially expressed genes after hTR overexpression in U2OS cells 7.57
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 7.56
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 7.55
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 7.55
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 7.53
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 7.46
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 7.37
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 7.35
U2AF1 mutations alter splice site recognition in hematological malignancies 7.34
Oncogenic MYC induces a dependency on the spliceosome in human cancer 7.31
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 7.25
RNA splicing alteration on glioblastoma and normal neural stem cells 7.19
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 7.19
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 7.14
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 7.14
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 7.11
Differential Gene Expression between MCF10A and MCF7 cells 7.01
RNA-Seq in neutrophils from Antiphospholipid Syndrome 6.98
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 6.96
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 6.94
Biological effect of chronic mistranslation in mammalian cells 6.91
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 6.88
Proliferation-correlated expression 6.81
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 6.8
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 6.8
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 6.73
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 6.68
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 6.63
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 6.61
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 6.6
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 6.56
Role of COP1 on MAP kinase transcriptional output in melanoma 6.47
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 6.43
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 6.4
RNA-Seq from human ILC transitional populations 6.37
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 6.37
ARID1A and ARID1B loss in HCT116 and TOV21G cells 6.35
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 6.35
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 6.32
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 6.29
Gene expression profiling of leukemia cells following asparagine depletion 6.23
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 6.23
Exploring ILF2 regulatory genes by next-generation sequencing 6.14
Effect of FGF13 depletion on the H460 cell line 6.13
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 6.12
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 6.08
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 6.07
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 6.01
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 5.92
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 5.89
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 5.89
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 5.74
RNA-seq of shEZH2 cells 5.71
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 5.69
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 5.68
Analysis of transcriptional regulation by Myt1 and Myt1l 5.64
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 5.64
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 5.6
Molecular Criteria for Defining the Naive Human Pluripotent State 5.58
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 5.55
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 5.44
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 5.44
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 5.42
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 5.42
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 5.35
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 5.33
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 5.33
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 5.29
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 5.16
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 5.12
The age and genomic integrity of neurons after cortical stroke in humans 5.11
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 5.04
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 4.98
RNAseq in Alzheimer's Disease patients 4.94
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 4.94
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 4.94
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 4.92
Integrating single-cell transcriptomic data across different conditions, technologies, and species 4.89
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 4.89
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 4.85
siRNA-mediated knockdown 4.8
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 4.8
Finding missing proteins from epigenetically manipulated human cells 4.74
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 4.68
CDK4/6 inhibitor resistance in prostate cancer 4.64
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 4.64
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 4.63
Transcriptome of activated human and mouse MAIT cells 4.6
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 4.59
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 4.57
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 4.54
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 4.39
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 4.39
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 4.38
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 4.36
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 4.35
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 4.29
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 4.24
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 4.2
Identification of differentially expressed genes between senescence and senescence bypass cells 4.2
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 4.17
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 4.15
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 4.12
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 4.04
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 4.02
RNA-seq of MDA-MB-231 cells with TET1 knockout 4.01
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 4.0
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 4.0
BCL11B 3.82
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 3.81
Universal alternative splicing of noncoding exons 3.79
Activity-dependent transcriptional changes in human neurons 3.75
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 3.71
Ectoderm specification of H1 human embryonic stem cells 3.71
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 3.65
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.61
TOP2B disturbed the quality of human oocytes with advanced maternal age 3.57
Anti-inflammatory effect of indoleacrylic acid (IA) 3.55
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 3.51
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 3.45
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 3.39
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 3.39
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 3.38
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 3.32
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 3.19
Gene expression in GBM with Cav3.2 inhibition 3.15
Role of cervicovaginal microbiota in genital inflammation 3.12
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 3.12
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 3.03
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 3.01
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 3.0
Human Tfh cell RNA bulk sequencing 2.94
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 2.93
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 2.93
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.84
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.84
LIN28A Over-expression RNAseq 2.79
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 2.75
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 2.72
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  2.72
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.71
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.71
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 2.68
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 2.67
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 2.65
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.64
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.63
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 2.42
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 2.35
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.33
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 2.3
Positively selected enhancer elements endow tumor cells with metastatic competence 2.26
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.26
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.15
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.15
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.15
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 2.14
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 2.12
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 2.09
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 2.08
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.01
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.01
quanTIseq: quantifying immune contexture of human tumors 1.98
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.98
Transcriptional landscape changes during human embryonic stem cell derivation 1.9
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.86
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.86
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.84
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.84
Modulation of nonsense-mediated decay by rapamycin 1.84
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 1.78
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.7
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.59
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.59
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 1.58
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.57
RNA-seq data 1.51
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 1.51
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.5
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 1.49
Human islets of varying quality: the good, the (not so) bad and the ugly 1.48
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 1.4
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 1.39
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.38
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.38
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.34
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.32
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.31
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.26
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 1.24
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 1.24
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.22
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.19
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.13
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.12
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.12
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.05
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 1.03
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.97
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.94
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 0.91
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.9
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.87
RNA-seq of IL-4 stimulated human keratinocytes 0.86
HBEC-shp53-PCHD7 0.83
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 0.77
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.77
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.75
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.75
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.74
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.74
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.74
High-resolution comparative analysis of great ape genomes 0.73
HEK293 TFAM Knockout Expression Study 0.73
Ribosome profiling upon inhibition of eIF4A 0.7
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.69
Aging-associated patterns in the expression of human endogenous retroviruses 0.68
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 0.66
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.54
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.53
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.52
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.46
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.45
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.45
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.4
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.4
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.39
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.38
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.34
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.33
Gene expression changes due to PARP knockdown in human cells 0.31
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.29
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.27
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 0.26
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.12
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 0.1


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation